ExoOne has been granted approval by the Ministry of Health and Welfare to use human-derived exosomes as cosmetic ingredients, marking the first case in Taiwan.

ExoOne Bio, a subsidiary of TTY Biopharm, announced on the 25th that it has officially received approval from the Food and Drug Administration of the Ministry of Health and Welfare to become the first company in Taiwan to use human cell-derived exosomes as cosmetic ingredients. ExoOne Chairman Lin Tsou-yen stated that the company will gradually launch four products including ampoules, essences, masks, and hair care solutions in the domestic market, targeting medical aesthetics clinics, e-commerce platforms, and pharmacies. The company aims to achieve a revenue target of 50 million NT dollars in the first year and expects revenue to multiply from next year.